415 Capital Management GmbH
415capital.com Direct investor
415 Capital Management GmbH is a venture capital firm based in Munich, Germany, that invests in medical technology companies. It focuses on clinical through commercial stage companies in Europe, Israel, and North America.
415 Capital Management GmbH is a venture capital firm headquartered in Munich, Germany. It invests directly in companies, in medical Technologies, structural Heart Disease, heart Failure and aortic & Peripheral Vascular Disease. Its stated cheque size is €5-15 Million per Company.
“415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation.”
— 415 Capital Management GmbH, own website
- Layer
- Direct investor
- Type
- Venture capital
- Stage
- Not stated
- Invests in
- Europe, Israel, North America
- Sectors
- Medical Technologies, Structural Heart Disease, Heart Failure, Aortic & Peripheral Vascular Disease, Neurovascular Disease / Stroke, Hypertension, Electrophysiology, Neuromodulation for Chronic Diseases
- Cheque size
- €5-15 Million per Company
- How to reach it
- Its pitch / apply page on its own site
Team, as 415 Capital Management GmbH publishes it
- Frederik Groenewegen General Partner
- David Thompson General Partner
- Azin Parhizgar Managing Director, US
- Ruben Osnabrugge Partner & Chief Medical Officer
- Linus Rieder Principal
- Amra Habich Executive Assistant
- Eduardo Palma Associate
- Julia Hoffmeister Senior Investment Analyst
- Matheus Abizaid Investment Analyst
- Anna Yildiran Investment Intern
- Hershel Groenewegen Chief Happiness Officer
- Frank Groenewegen Chairman Emeritus
Names and roles exactly as listed on 415capital.com. Nothing else about these people is recorded.
Most shared portfolio companies with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 13 investors with a shared portfolio company. A shared company is not proof they invested together in the same round.
- M&L Group 3 shared companies: endovascularengineering.com, corflow.com, r3vascular.com
- Molten Ventures 1 shared company: hilo.com
- 4see Ventures 1 shared company: distalmotion.com
- Biopôle 1 shared company: distalmotion.com
- Privilège Ventures 1 shared company: distalmotion.com
- Revival Healthcare Capital 1 shared company: distalmotion.com
- Zühlke Ventures 1 shared company: distalmotion.com
- Andera Partners 1 shared company: tricares.com
- Go Capital 1 shared company: tricares.com
- Karista 1 shared company: tricares.com
and 3 more — the graph.
Where this comes from
Every fact above was read from a page 415 Capital Management GmbH publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://415capital.com/name, is_investor, layer, type, hq_country, hq_city, thesis_quote, description, status, confidence
- https://415capital.com/about/invests_in_geographies, stage_min, stage_max, sectors, cheque_size, approach_url
- https://415capital.com/team/people
Record 9293 · added 2026-09-29 · link last verified 2026-10-21 · confidence high
Similar investors
- Acton Capital Partners GmbHVenture capital · Series A – Growth · Munich, Germany
- Alpine Space Ventures Management GMBHVenture capital · Seed – Series A · Munich, Germany
- Amathaon CapitalVenture capital · Munich, Germany
- Ananda Impact VenturesVenture capital · Pre-seed – Series A · Munich, Germany
- AQAL CapitalVenture capital · Seed – Series A · Munich, Germany
- CARMA FUND IVenture capital · Pre-seed – Series A · Munich, Germany